Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-TNFR2 monoclonal antibody HFB200301

A humanized agonistic monoclonal antibody directed against tumor necrosis factor receptor 2 (TNFR2; tumor necrosis factor receptor superfamily member 1B; TNFRSF1B), with potential antineoplastic activity. Upon administration, anti-TNFR2 monoclonal antibody HFB200301 targets and binds to TNFR2 expressed on the surface of CD4+ T cells, CD8+ T cells and natural killer (NK) cells in the tumor micro-environment (TME), thereby activating CD4+ T cells, CD8+ T cells and NK cells. This may enhance T-cell- and NK cell- mediated immune responses against tumor cells. TNFR2, a member of the TNFR family of co-stimulatory molecules, plays an important role in T-cell co-stimulation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-TNFR2 agonist antibody HFB200301
Code name:HFB 200301
HFB-200301
HFB200301
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search